Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: A retrospective cohort study

Journal of Neurosurgery

Volumn 124, Issue 3, 2016, Pages 750-759

  Guha, Daipayan ^a,b   Coyne, Shona ^c   Macdonald, R Loch ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Anticoagulation; Antiplatelet; Antithrombosis; Chronic subdural hematoma; Vascular disorders

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; APIXABAN; CLOPIDOGREL; DABIGATRAN; DALTEPARIN; DIPYRIDAMOLE; ENOXAPARIN; FONDAPARINUX; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN COMPLEX; RIVAROXABAN; VITAMIN K GROUP; WARFARIN; FIBRINOLYTIC AGENT;

AGED; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; ATHEROSCLEROSIS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CRANIECTOMY; CRANIOTOMY; DEEP VEIN THROMBOSIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBDURAL HEMATOMA; SURGICAL DRAINAGE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TRANSIENT ISCHEMIC ATTACK; DRAINAGE; DRUG ADMINISTRATION; HEMATOMA, SUBDURAL, CHRONIC; MIDDLE AGED; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CRANIOTOMY; DRAINAGE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HEMATOMA, SUBDURAL, CHRONIC; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84975126991     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2015.2.JNS141889     Document Type: Article

References (32)

1. Asghar M, Adhiyaman V, Greenway MW, Bhowmick BK, Bates A: Chronic subdural haematoma in the elderly-A North Wales experience. J R Soc Med 95:290-292, 2002
2. Aspegren OP, Astrand R, Lundgren MI, Romner B: Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg 115:981-984, 2013
3. Baechli H, Nordmann A, Bucher HC, Gratzl O: Demographics and prevalent risk factors of chronic subdural haematoma: results of a large single-center cohort study. Neurosurg Rev 27:263-266, 2004
4. Bourgeois P, Sleiman M, Louis E, Haddad E, Touzet G, Fichten A, et al: [Chronic subdural hematoma in patients over 80 years of age.] Neurochirurgie 45:124-128, 1999 (Fr)
5. Campbell PG, Sen A, Yadla S, Jabbour P, Jallo J: Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: A clinical review. World Neurosurg 74:279-285, 2010
6. Chari A, Clemente Morgado T, Rigamonti D: Recommencement of anticoagulation in chronic subdural haematoma: A systematic review and meta-analysis. Br J Neurosurg 28:2-7, 2014
7. Chon KH, Lee JM, Koh EJ, Choi HY: Independent predictors for recurrence of chronic subdural hematoma. Acta Neurochir (Wien) 154:1541-1548, 2012
8. Connolly S, Pogue J, Hart R, Pfeffer M, Hohnloser S, Chrolavicius S, et al: Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): A randomised controlled trial. Lancet 367:1903-1912, 2006
9. Cousseau DH, Echevarría Martín G, Gaspari M, Gonorazky SE: [Chronic and subacute subdural haematoma. An epidemiological study in a captive population.] Rev Neurol 32:821-824, 2001 (Span)
10. Ducruet AF, Grobelny BT, Zacharia BE, Hickman ZL, DeRosa PL, Anderson K, et al: The surgical management of chronic subdural hematoma. Neurosurg Rev 35:155-169, 2012
11. Forster MT, Mathé AK, Senft C, Scharrer I, Seifert V, Gerlach R: The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci 17:975-979, 2010
12. Fuster V, Mearns BM: The CVD paradox: mortality vs prevalence. Nat Rev Cardiol 6:669, 2009
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864-2870, 2001
14. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al: Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370-2375, 2001
15. Gonugunta V, Buxton N: Warfarin and chronic subdural haematomas. Br J Neurosurg 15:514-517, 2001
16. Hawryluk GW, Austin JW, Furlan JC, Lee JB, O'Kelly C, Fehlings MG: Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 8:1500-1508, 2010
17. He W, Sengupta M, Velkoff VA, DeBarros KA: 65+ in the United States: 2005. Washington DC: US Census Bureau, 2005
18. Kawamata T, Takeshita M, Kubo O, Izawa M, Kagawa M, Takakura K: Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol 44:438-443, 1995
19. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factorbased approach: The euro heart survey on atrial fibrillation. Chest 137:263-272, 2010
20. Majeed A, Kim YK, Roberts RS, Holmström M, Schulman S: Optimal timing of resumption of warfarin after intracranial hemorrhage. Stroke 41:2860-2866, 2010
21. Mori K, Maeda M: Surgical treatment of chronic subdural hematoma in 500 consecutive cases: clinical characteristics, surgical outcome, complications, and recurrence rate. Neurol Med Chir (Tokyo) 41:371-381, 2001
22. Nakaguchi H, Tanishima T, Yoshimasu N: Factors in the natural history of chronic subdural hematomas that influence their postoperative recurrence. J Neurosurg 95:256-262, 2001
23. Okano A, Oya S, Fujisawa N, Tsuchiya T, Indo M, Nakamura T, et al: Analysis of risk factors for chronic subdural haematoma recurrence after burr hole surgery: optimal management of patients on antiplatelet therapy. Br J Neurosurg 28:204-208, 2014
24. Rogacka R, Chieffo A, Michev I, Airoldi F, Latib A, Cosgrave J, et al: Dual antiplatelet therapy after percutaneous coronary intervention with stent implantation in patients taking chronic oral anticoagulation. JACC Cardiovasc Interv 1:56-61, 2008
25. Rust T, Kiemer N, Erasmus A: Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci 13:823-827, 2006
26. Santarius T, Kirkpatrick PJ, Ganesan D, Chia HL, Jalloh I, Smielewski P, et al: Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: A randomised controlled trial. Lancet 374:1067-1073, 2009
27. Stanisic M, Lund-Johansen M, Mahesparan R: Treatment of chronic subdural hematoma by burr-hole craniostomy in adults: influence of some factors on postoperative recurrence. Acta Neurochir (Wien) 147:1249-1257, 2005
28. Tahsim-Oglou Y, Beseoglu K, Hänggi D, Stummer W, Steiger HJ: Factors predicting recurrence of chronic subdural haematoma: The influence of intraoperative irrigation and low-molecular-weight heparin thromboprophylaxis. Acta Neurochir (Wien) 154:1063-1068, 2012
29. Torihashi K, Sadamasa N, Yoshida K, Narumi O, Chin M, Yamagata S: Independent predictors for recurrence of chronic subdural hematoma: A review of 343 consecutive surgical cases. Neurosurgery 63:1125-1129, 2008
30. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th Revision. Geneva: World Health Organization, 2011
31. Yeon JY, Kong DS, Hong SC: Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma 29:1334-1341, 2012
32. Yorkgitis BK, Ruggia-Check C, Dujon JE: Antiplatelet and anticoagulation medications and the surgical patient. Am J Surg 207:95-101, 2014